SLAM
TMDX icon

Swiss Life Asset Management’s Transmedics TMDX Stock Holding History

Swiss Life Asset Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,698
Closed -$368K – 1732
2026
Q1 		$368K Buy
3,698
+700
+23% +$91.3K ﹤0.01% 1015
2025
Q4 		$365K Buy
+2,998
New +$376K ﹤0.01% 924

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Swiss Life Asset Management's TMDX Position: Q2 2026 in Review

Swiss Life Asset Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 3,698 shares — an estimated $368K sold.

Swiss Life Asset Management first reported a position in TMDX in Q4 2025 and held it in 2 quarters. The position peaked at $368K in Q1 2026. 281 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Swiss Life Asset Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Swiss Life Asset Management sold 3,698 Transmedics shares in Q2 2026, an estimated $368K.
  • Swiss Life Asset Management first reported a position in Transmedics in Q4 2025 and held it in 2 quarters.
  • Swiss Life Asset Management's Transmedics position peaked at $368K in Q1 2026.
  • 281 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.